296 related articles for article (PubMed ID: 34938730)
1. Identification of Therapeutic Targets and Prognostic Biomarkers Among Chemokine (C-C Motif) Ligands in the Liver Hepatocellular Carcinoma Microenvironment.
Jiang Z; Xing C; Wang P; Liu X; Zhong L
Front Cell Dev Biol; 2021; 9():748269. PubMed ID: 34938730
[No Abstract] [Full Text] [Related]
2. Identification of Therapeutic Targets and Prognostic Biomarkers Among CXC Chemokines in the Renal Cell Carcinoma Microenvironment.
Zeng Q; Sun S; Li Y; Li X; Li Z; Liang H
Front Oncol; 2019; 9():1555. PubMed ID: 32117786
[No Abstract] [Full Text] [Related]
3. The Prognostic Significance of
Li Z; Cui Y; Duan Q; Zhang J; Shao D; Cao X; Gao Y; Wang S; Li J; Jones OD; Lei X; Wang L; Zhou X; Xu M; Ma J; Liu Y; Xu X
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361587
[TBL] [Abstract][Full Text] [Related]
4. Identification of therapeutic targets and prognostic biomarkers among CXC chemokines in hepatocellular carcinoma microenvironment.
Yin Z; Ma T; Chen S; Yu M
Cancer Biomark; 2023; 36(3):231-250. PubMed ID: 36938723
[TBL] [Abstract][Full Text] [Related]
5. CD93 overexpresses in liver hepatocellular carcinoma and represents a potential immunotherapy target.
Jiang Q; Kuai J; Jiang Z; Que W; Wang P; Huang W; Ding W; Zhong L
Front Immunol; 2023; 14():1158360. PubMed ID: 37483608
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value and immunological role of BAIAP2L2 in liver hepatocellular carcinoma: A pan-cancer analysis.
Han X; Long W; Liu Y; Xu J
Front Surg; 2022; 9():985034. PubMed ID: 36338652
[TBL] [Abstract][Full Text] [Related]
7. Identification of immune-related biomarkers associated with tumorigenesis and prognosis in cutaneous melanoma patients.
Huang B; Han W; Sheng ZF; Shen GL
Cancer Cell Int; 2020; 20():195. PubMed ID: 32508531
[TBL] [Abstract][Full Text] [Related]
8. CCL14 is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma.
Gu Y; Li X; Bi Y; Zheng Y; Wang J; Li X; Huang Z; Chen L; Huang Y; Huang Y
Aging (Albany NY); 2020 Jan; 12(1):784-807. PubMed ID: 31927532
[TBL] [Abstract][Full Text] [Related]
9.
Tan Z; Chen M; Peng F; Yang P; Peng Z; Zhang Z; Li X; Zhu X; Zhang L; Zhao Y; Liu Y
Transl Cancer Res; 2022 Aug; 11(8):2713-2732. PubMed ID: 36093522
[TBL] [Abstract][Full Text] [Related]
10. CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma.
Su J; Huang Y; Wang Y; Li R; Deng W; Zhang H; Xiong H
Cancer Cell Int; 2022 Feb; 22(1):67. PubMed ID: 35139863
[TBL] [Abstract][Full Text] [Related]
11. Functions of CXC chemokines as biomarkers and potential therapeutic targets in the hepatocellular carcinoma microenvironment.
Wang J; Zhang C; Chen X; Li Y; Li A; Liu D; Li F; Luo T
Transl Cancer Res; 2021 May; 10(5):2169-2187. PubMed ID: 35116536
[TBL] [Abstract][Full Text] [Related]
12. PDCL3 is a prognostic biomarker associated with immune infiltration in hepatocellular carcinoma.
Jin W; Wang G; Dong M; Wang X
Eur J Med Res; 2024 Mar; 29(1):177. PubMed ID: 38494503
[TBL] [Abstract][Full Text] [Related]
13. Exploration of prognostic biomarkers and therapeutic targets in the microenvironment of bladder cancer based on CXC chemokines.
Sun X; Chen Q; Zhang L; Chen J; Zhang X
Math Biosci Eng; 2021 Jul; 18(5):6262-6287. PubMed ID: 34517533
[TBL] [Abstract][Full Text] [Related]
14. ACYP1 Is a Pancancer Prognostic Indicator and Affects the Immune Microenvironment in LIHC.
Zhou L; Fu Z; Wang S; Jia J; Cheng Y; Zheng Y; Zhang N; Lu W; Yao Z
Front Oncol; 2022; 12():875097. PubMed ID: 35586489
[TBL] [Abstract][Full Text] [Related]
15. Ferroptosis regulator SLC7A11 is a prognostic marker and correlated with PD-L1 and immune cell infiltration in liver hepatocellular carcinoma.
Liang Y; Su S; Lun Z; Zhong Z; Yu W; He G; Wang Q; Wang J; Huang S
Front Mol Biosci; 2022; 9():1012505. PubMed ID: 36267158
[No Abstract] [Full Text] [Related]
16. Exploration of potential therapeutic and prognostic value of CXC chemokines in cervical squamous cell carcinoma and endocervical adenocarcinoma based on bioinformatics analysis.
Wu C; Ma C; Yuan J; Zhou P
Math Biosci Eng; 2021 Sep; 18(6):8201-8222. PubMed ID: 34814296
[TBL] [Abstract][Full Text] [Related]
17. Correlation analysis of RDM1 gene with immune infiltration and clinical prognosis of hepatocellular carcinoma.
Qiu C; Li Z; Cao W; Cai X; Ye L; Zhang C; Ma Y; Wang X; Yang Y
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34435618
[TBL] [Abstract][Full Text] [Related]
18. Identification of ABCC5 Among ATP-Binding Cassette Transporter Family as a New Biomarker for Hepatocellular Carcinoma Based on Bioinformatics Analysis.
Qiu Y; Li H; Xie J; Qiao X; Wu J
Int J Gen Med; 2021; 14():7235-7246. PubMed ID: 34737618
[TBL] [Abstract][Full Text] [Related]
19. A novel prognostic biomarker:
Lai T; Peng T; Li J; Jiang Y; Liu K; Yu W; Yao N; Hu Y; Cao M; Liang J
Transl Cancer Res; 2023 May; 12(5):1145-1164. PubMed ID: 37304536
[TBL] [Abstract][Full Text] [Related]
20. ASPM Is a Prognostic Biomarker and Correlates With Immune Infiltration in Kidney Renal Clear Cell Carcinoma and Liver Hepatocellular Carcinoma.
Deng T; Liu Y; Zhuang J; Tang Y; Huo Q
Front Oncol; 2022; 12():632042. PubMed ID: 35515103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
